Literature DB >> 7713255

Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy.

S J Talks1, N H Chong, J M Gibson, P M Dodson.   

Abstract

Non-arteritic anterior ischaemic optic neuropathy (AION) is thought to be due to occlusion of the posterior ciliary circulation. Raised lipid and fibrinogen concentrations are recognised risk factors for vessel occlusion in cardiovascular disease and stroke but, although suspected as risk factors in non-arteritic AION, they have not been studied in this condition. We therefore performed a case-control study on 41 patients with non-arteritic AION, looking at these and other atherosclerotic risk factors. The odds ratio of cholesterol being > 6.5 mmol/l in non-arteritic AION was 2.7 (95% confidence interval 1.09 to 6.65; p < 0.05) and of fibrinogen being > 3.6 g/l was 5 (2.66 to 9.39; p < 0.05). Smoking was also found to be significantly associated with non-arteritic AION, the odds ratio being 16 (3.23 to 79.23; p < 0.001). These were the only risk factors found to be significantly associated with non-arteritic AION. This raises the possibility that appropriate medical management of these factors could be given to prevent recurrence in the fellow eye.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713255     DOI: 10.1038/eye.1995.13

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Application of HELP in nonarteritic anterior ischemic optic neuropathy: a prospective, randomized, controlled study.

Authors:  A Haas; M Walzl; F Jesenik; B Walzl; A Berghold; J Berglöff; B Feigl; J Faulborn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

2.  Risk Factors for Non-arteritic Anterior Ischaemic Optic Neuropathy in a Korean Population.

Authors:  Dae Hyun Kim; Gwang Rae Shin; Young Je Choi
Journal:  Neuroophthalmology       Date:  2017-01-11

3.  Trombophilic screening for nonarteritic anterior ischemic optic neuropathy.

Authors:  Valeria Nagy; Zita Steiber; Lili Takacs; Gyorgy Vereb; Andras Berta; Zsuzsanna Bereczky; Gyorgy Pfliegler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

4.  Imageology of internal carotid artery siphon in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Zhi-Yong Fu; Hong-Yang Li; Yan-Ling Wang
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

Review 5.  Positioning patients for spine surgery: Avoiding uncommon position-related complications.

Authors:  Ihab Kamel; Rodger Barnette
Journal:  World J Orthop       Date:  2014-09-18

6.  Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy.

Authors:  M Weger; O Stanger; H Deutschmann; M Simon; W Renner; O Schmut; J Semmelrock; A Haas
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

7.  Non-arteritic anterior ischaemic optic neuropathy: evaluation of the brain and optic pathway by conventional MRI and magnetisation transfer imaging.

Authors:  Maria I Argyropoulou; Anastasia K Zikou; Ioanna Tzovara; Alexios Nikas; Kostandinos Blekas; Persefoni Margariti; Nikolaos Galatsanos; Ioannis Asproudis
Journal:  Eur Radiol       Date:  2006-11-28       Impact factor: 5.315

8.  Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study.

Authors:  Barbara Giambene; Andrea Sodi; Francesco Sofi; Rossella Marcucci; Sandra Fedi; Rosanna Abbate; Domenico Prisco; Ugo Menchini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-04       Impact factor: 3.117

9.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

10.  Atherogenic indices in non-arteritic ischemic optic neuropathy.

Authors:  Nurullah Koçak; Volkan Yeter; Mustafa Turunç; Merve Bayrambaş; Bilge Eraydın; İnci Güngör
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.